Want a downturn in European markets? In your inbox before opening, every day. Sign up here. AstraZeneca plc said it would buy Alexian added 39 39 billion in cash and shares to Alexian Pharmaceuticals Inc., an expert in the development of treatments for rare diseases and immunology. The offer gives …
Read More »